LYRA·55234L105·UQ·equity·Healthcare - Biotechnology-Activist
LYRA (Lyra Therapeutics, Inc.) is held by 0 institutional investors as of Q1 2026. Net institutional sentiment: Bearish.
See how LYRA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer